SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-010340
Filing Date
2017-09-08
Accepted
2017-09-08 09:00:38
Documents
4
Period of Report
2017-08-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 35171
2 ex99-1.htm EX-99.1 33598
3 ex99-1_001.jpg GRAPHIC 81364
4 ex99-1_002.jpg GRAPHIC 20642
  Complete submission text file 0001493152-17-010340.txt   210761
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54933 | Film No.: 171075177
SIC: 2834 Pharmaceutical Preparations